Navigation Links
Masimo Reports Second Quarter 2011 Financial Results
Date:8/9/2011

website or otherwise.  We do not undertake any obligation to update, amend or clarify these forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Investor Contact: Sheree AronsonMedia Contact: Dana BanksVice President, Investor Relations, Masimo CorporationDirector, Corporate Communications, Masimo Corporation (949) 297-7043 (949) 297-7348 saronson@masimo.comdbanks@masimo.comMasimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Rainbow Acoustic Monitoring, RRa, Radical-7, Rad-87, Rad-57, Rad-8, Rad-5,Pulse CO-Oximetry, Pulse CO-Oximeter, and SEDLine are trademarks or registered trademarks of Masimo Corporation.

MASIMO CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited, in thousands) July 2,January 1,20112011ASSETSCurrent assetsCash and cash equivalents

$

125,694$

88,305Accounts receivable, net of allowance for doubtful accounts 52,03649,694Royalties receivable7,25212,000Inventories44,95445,028Prepaid expenses9,9767,887Deferred tax assets12,56112,555Other current assets1,8062,136Total current assets254,279217,605Deferred cost of goods sold52,38047,184Property and equipment, net15,13215,951Intangible assets, net10,47210,497Deferred tax assets12,57912,560Other assets6,9006,438Total assets

$

351,742$

310,235LIABILITIES AND EQUITYCurrent liabilitiesAccounts payable

$

20,127$

22,150Accrued compensation15,08721,074Accrued liabilities10,4269,832Income taxes payable1,327722Deferred revenue15,26816,369Current portion of capital lease obligations4750Total current liabilities62,28270,197Deferred revenue1,2621,554Capital lease obligations, less current p
'/>"/>

SOURCE Masimo Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Masimo Announces Adoption of Stock Repurchase Program
2. Masimo Introduces Pronto-7™ Internationally and Lifts Voluntary Recall
3. Masimo to Report Second Quarter 2011 Financial Results after Market Close on August 9, 2011
4. Masimo and Dartmouth-Hitchcock Medical Center, First Cross-Industry Collaborative Honored With the Institute for Technology and Healthcare Clinical Application Award
5. Masimo Announces Rainbow Agreement with Philips
6. Masimo Pronto-7 Wins GOLD in the 2011 Medical Design Excellence Award Competition—the Premier Awards Program for the Medical Technology Community
7. Masimo Initiates Limited Market Release of E1, Single-Patient-Use Ear Sensor for Pulse Oximetry Monitoring
8. Masimo to Present at Goldman Sachs 32nd Annual Global Healthcare Conference
9. Masimo Reports First Quarter 2011 Financial Results
10. Masimo Launches New Reusable SpCO® Sensor with Improved Accuracy and Reliability in Low Oxygen Saturation and Elevated Methemoglobin States
11. New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... SAN FRANCISCO , June 29, ... company,s novel blood-draw technology has received CE Mark ... quality from the European Union. This regulatory milestone ... alternative to one of the most common procedures ... Velano Vascular,s proprietary device reduces the ...
(Date:6/29/2015)... , June 29, 2015 ... and predicted revenues ,Where is the market for dermatological ... market? Visiongain ,s new report shows you potential ... and prospects. Our 310 page report ... most lucrative areas in the industry and the future ...
(Date:6/29/2015)... Calif. , June 29, 2015  The ... innovative features to cars on the basis of ... The industry is now on the verge of ... cars. While automotive HWW non-critical features such as ... be present in 30 to 40 percent of ...
Breaking Medicine Technology:Velano Vascular Receives CE Mark For Novel Blood Draw Technology Designed to Reduce Needle Exposures for Hospitalized Patients and Healthcare Providers 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 2Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 3Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 4Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 5Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 6Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 7Dermatological Drugs Market Forecast 2015-2025 Opportunities for Leading Companies 8Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 2Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 3Convergence Trends See the Automotive Industry Integrate Health, Wellness and Wellbeing into Vehicles 4
... Expected in November 2008, BOTHELL, Wash., Oct. 9 ... the completion of patient enrollment and dosing,for the third ... and,efficacy of its formulation of 12-hour extended-release (ER) ibuprofen ... top-line,results from this pivotal trial in November 2008. Ibuprofen ...
... Will Reduce Animal Use in Cosmetics and Chemicals ... Corp. today announced,that results of a recently completed ... EpiDerm in vitro human skin tissue,equivalent. The test ... to be accepted as a validated alternative to ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3MatTek's EpiDerm In Vitro Tissues Headed for Validation in Europe 2
(Date:6/29/2015)... San Fernando Valley, CA (PRWEB) , ... June 29, 2015 , ... ... offering non-invasive treatments designed to lift and tighten sagging skin. Ulthera is a special ... or surgery. Instead, it uses ultrasound technology to gently stimulate collagen production. Ulthera is ...
(Date:6/29/2015)... New York, NY (PRWEB) , ... June 29, ... ... health dietary supplement with Citicoline (Cognizin®) from Kyowa Hakko Bio to French consumers. ... protect the macular cells from oxidative stress caused by free radicals. In addition ...
(Date:6/29/2015)... Eagan, Minnesota (PRWEB) , ... June 29, 2015 ... ... Cross) today announced the promotion of two leaders with the Commercial Markets division, ... individuals, small and large employers, and Minnesota-headquartered companies with regional, national and international ...
(Date:6/29/2015)... (PRWEB) , ... June 29, 2015 , ... ... and pharmacist guided, safe, informed, responsible and legal access to Health Canada's medical ... West. , NAC provides education on how Health Canada's medical marijuana system works. ...
(Date:6/29/2015)... ... 29, 2015 , ... Visiting retirement communities and interviewing at-home caregivers has just ... search for senior care on http://www.SeniorsGuideOnline.com . , The helpful “cheat” sheets, like ... assisted living , rehab, and nursing home communities . , “’What to Ask ...
Breaking Medicine News(10 mins):Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 2Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Non-Invasive Skin Tightening Procedures 3Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 2Health News:Bionops Laboratory Releases Biomacula, the First French Product with Citicoline (Cognizin®) 3Health News:Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division 2Health News:Blue Cross and Blue Shield of Minnesota announces two new leadership appointments within its Commercial Markets division 3Health News:National Access Cannabis Opens Flagship Ottawa Care Centre 2Health News:National Access Cannabis Opens Flagship Ottawa Care Centre 3Health News:New Checklists and Question Sheets for Visiting Retirement Communities, Interviewing Home Health Caregivers Available From Seniors Guide 2Health News:New Checklists and Question Sheets for Visiting Retirement Communities, Interviewing Home Health Caregivers Available From Seniors Guide 3
... function problems in ill veterans , , TUESDAY, March 24 ... 1991 Gulf War appears to have triggered abnormal responses ... found. , They say the discovery could lead to ... Gulf War syndrome. , The study, from the ...
... eating fish, study finds , , TUESDAY, March 24 (HealthDay ... against advanced prostate cancer, researchers report. , Eating fish ... of developing advanced prostate cancer even if one is ... is needed to see if the association is real, ...
... against advanced prostate cancer, and this effect may be ... according to a report in Clinical Cancer Research ... Research. , "Previous research has shown protection against prostate ... to show protection against advanced prostate cancer and interaction ...
... YORK, March 24, 2009 Researchers may have found a more ... history of the deadly skin disease. In a new study, scientists ... to a nearly four-fold increase of melanoma in women under the ... 24, 2009, in the journal Clinical Cancer Research and ...
... WASHINGTONThe World Health Organization released staggering new data about the ... with HIV/AIDS today, in recognition of World TB Day. ... previously thought, the new WHO figures show. In 2007, there ... 15 percent of the total incident cases. That,s double the ...
... students who are problem drinkers using alcohol to cope ... to continue excessive drinking into adulthood, a recent study ... that adults who are still high-risk drinkers by age ... social and cognitive development that typically occurs during college, ...
Cached Medicine News:Health News:Gulf War Syndrome May Stem From Chemical Exposure 2Health News:Omega-3 Fatty Acids Guard Against Advanced Prostate Cancer 2Health News:Omega-3 Fatty Acids Guard Against Advanced Prostate Cancer 3Health News:NYU study finds new risk factor for melanoma in younger women 2Health News:NYU study finds new risk factor for melanoma in younger women 3Health News:Alarming new data shows TB-HIV co-infection a bigger threat 2Health News:Study helps identify college drinkers who might continue excessive drinking as adults 2Health News:Study helps identify college drinkers who might continue excessive drinking as adults 3Health News:Study helps identify college drinkers who might continue excessive drinking as adults 4Health News:Study helps identify college drinkers who might continue excessive drinking as adults 5
... A concentrated enzymatic cleanser ... semi-automated hematology instruments. It ... all Abbott CELL-DYN® hematology ... instruments. The shelf life ...
Streck-CD3500 Hemoglobin/Lyse is a lytic reagent for the quantitative determination of hemoglobin on the Abbott CELL-DYN® 3500 and 3700. The shelf life is two years from the date of manufacture....
Streck-Diluent III Plus is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 3000, 3500 and 3700. The shelf...
Streck-Diluent IIIA is a balanced electrolyte solution manufactured specifically for use as a diluent for blood cell counting and sizing on the Abbott CELL-DYN® 1700. The shelf life is one year f...
Medicine Products: